IGF1 and obesity disorder: Notably, circulating IGF‐1 and IGFBP‐3 levels are both shown to be reduced in individuals with hepatic lipid accumulation (Mallea‐Gil et al., 2012; Min et al., 2016), a condition commonly observed in humans with obesity (Willis et al., 2021).